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Abstract – The objective of this work was to evaluate 210 Bacillus thuringiensis strains against Aedes aegypti
and Culex quinquefasciatus larvae to select the most effective. These strains were isolated from different
regions of Brazil and are stored in a Bacillus spp. collection at Embrapa Recursos Genéticos e Biotecnologia,
Brasília, Brazil. The selected strains were characterized by morphological (microscopy), biochemical (SDS-PAGE
10%) and molecular (PCR) methods. Six B. thuringiensis strains were identified as mosquito-toxic after the
selective bioassays. None of the strains produced the expected PCR products for detection of cry4, cry11 and
cyt1A genes. These results indicate that the activity of mosquitocidal Brazilian strains are not related with Cry4,
Cry11 or Cyt proteins, so they could be used as an alternative bioinsecticide against mosquitoes.
Index terms: Culex quinquefasciatus, Aedes aegypti, bioinsecticide.
Prospecção de estirpes de Bacillus thuringiensis efetivas contra mosquitos
 Resumo – Neste trabalho foram realizados testes de patogenicidade com 210 estirpes de Bacillus thuringiensis
contra larvas de Aedes aegypti e Culex quinquefasciatus, a fim de se determinar as mais eficazes. Estas estirpes
foram isoladas de diversas regiões do Brasil e estão armazenadas na coleção de Bacillus spp. da Embrapa
Recursos Genéticos e Biotecnologia. As estirpes selecionadas foram caracterizadas por métodos morfológicos
(microscopia), bioquímicos (SDS-PAGE 10%) e moleculares (Reação em Cadeia da Polimerase). Foram
selecionadas seis estirpes entomopatogênicas de Bacillus thuringiensis. Nenhuma das estirpes de Bacillus
thuringiensis apresentou produtos de PCR esperados para a detecção dos genes cry4, cry11 e cyt1A.
A patogenicidade das estirpes não está associada à presença das toxinas Cry4, Cry11 ou Cyt, assim, essas
estirpes poderão ser utilizadas para a formatação de um bioinseticida alternativo contra mosquitos.
Termos para indexação: Culex quinquefasciatus, Aedes aegypti, bioinseticida.
Introduction
In Brazil, some mosquito species of the family
Culicidae and Blackflies (Simulidae) are considerable
vectors of human and animal diseases. For example,
Aedes aegypti was responsible for more than 750,000
occurences of dengue fever in Brazil during the summer
of 2001/2002 (Vilarinhos, 2002).
Among the strategies used to control the endemic
vectors, the World Health Organization recommends the
use of bioinsecticides based on Bacillus thuringiensis
(WORLD HEALTH ORGANIZATION, 1985). The
advantages in using this bacterium are its specificity, the
absence of pollution and of toxicity to mammals, other
vertebrates or against plants (Whiteley & Schnepf,
1986). This bacterium exhibits high genetic variability,
producing more than 40 different classes of toxins against
insects of the orders Diptera, Lepidoptera and
Coleoptera (Feitelson et al., 1992). Researchers in
several parts of the world are looking for new strains of
B. thuringiensis that are able to produce new toxins.
Products based on this bacterium have been
commercialized around the world for more than 50 years.
At present, in Brazil, there has been no commercial
production of bioinsecticides based on this bacterium,
so that the products currently used are expensive, in
some cases preventing its utilization.
Embrapa Recursos Genéticos e Biotecnologia
maintains a culture collection of entomopathogenic
Bacillus spp. in which around 1,400 B. thuringiensis
(Bt) strains are stored (Monnerat et al., 2001).
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The aim of this work was to characterize the
B. thuringiensis strains of the Embrapa culture collection
and to identify strains that could be used to control
A. aegypti and Culex quinquefasciatus.
 Material and Methods
Two hundred and ten B. thuringiensis strains stored
in the collection of Entomopathogenic Bacillus spp. of
Embrapa Recursos Genéticos e Biotecnologia were
used. These strains were originally isolated from water
and soil samples collected from different Brazilian regions
(Monnerat et al., 2001).
Two kinds of bioassays were performed to determi-
ne the biological activity of the strains, a selective
bioassay to determine the pathogenic activity of the strain
and a quantified bioassay to determine the virulence of
the strains through determination of 50% lethal
concentration (LC50).
 All strains were grown in NYSM medium (Yousten,
1984) for 48 hours at 28°C and 200 rpm and tested
against 3rd instar larvae of C. quinquefasciatus and
A. aegypti. One mL of total culture of each strain was
added to 200 mL cups in triplicate with 100 mL of distilled
water and 25 larvae of C. quinquefasciatus or
A. aegypti. One cup without bacteria was used as the
control. Forty-eight hours later, the number of dead larvae
was evaluated. The strains that killed more than 50% of
the larvae were considered pathogenic (Silva-Werneck
& Monnerat, 2001).
In order to determine the LC50, several dilutions of
the lyophilised final culture prepared as described above
were used. One mL of these dilutions was added into
200 mL cups in triplicate, as for the procedure used in
selective bioassays. Forty-eight hours later the numbers
of dead larvae were recorded and the LC50 (lethal
concentration necessary to kill 50% of larvae) was
calculated by Probit analysis (Finney, 1971).
Bacillus thuringiensis israelensis (IPS-82, from the
Pasteur Institute) was used as standard.
For the analysis of protein profile, spore-crystal
mixtures of the B. thuringiensis strains and the standard
strain HD-1 were prepared by a rapid washing procedure
(Lecadet et al., 1992). Samples (1.5 mL) of sporulated
cultures were centrifuged at 11,750 g in a microcentrifuge
for 20 minutes and washed once in 1.5 mL of 0.5 M
NaCl and twice in cold sterilized water containing 1.0 mM
of the protease inhibitor, phenylmethylsulfonyl fluoride
(PMSF). The pellets were resuspended in 250 Lµ  of
1.0 mM PMSF and kept frozen at -20°C. The protein
composition of the spore-crystal mixtures was determined
by SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel
electrophoresis) with 10% acrylamide. Fifteen Lµ  of the
prepared sample was separated by electrophoresis at
125 V for two hours. Bacillus thuringiensis israelensis
(IPS-82, from the Pasteur Institute) was used as
standard.
The method used for analysis of the presence of
B. thuringiensis toxin genes by polymerase chain
reaction (PCR) was described by Bravo et al. (1998).
B. thuringiensis strains were grown on NYSM agar
for 16 hours, at 30°C. Cells were resuspended in MilliQ
water and frozen at -80°C for one hour and then
transferred to boiling water for 10 minutes to lyse the
cells. Primers designed for detecting genes cry4, cry11
and cyt1A were used. Fifteen Lµ  of supernatant obtained
from cell lysates of the B. thuringiensis strains were
transferred to a 200- Lµ  reaction tube containing
0.5 Mµ  of each primer, 0.2 mM of each dNTP, 1x Taq
polymerase buffer, 1.5 mM MgCl2 and 2.5 U of Taq
DNA polymerase in a final volume of 50 Lµ . PCR
amplification was performed with a Programmable
Thermal Controller. The conditions used for the PCRs
were those described by Carozzi et al. (1991) (cry4)
and Bravo et al. (1998) (cry11 and cyt). After
amplification, a 15- Lµ  sample of the product from each
PCR reaction was subjected to electrophoresis in a 2%
(w/v) agarose gel in Tris-borate buffer at 100 V for one
hour and stained with ethidium bromide.
Crystalline inclusions of each strain were purified
from the sporulated culture by centrifugation in
discontinuous sucrose gradient (Thomas & Ellar, 1983).
Each strain was grown on five nutrient agar plates, at
30°C, for 48 hours. The culture was collected in 20 mL
milliQ water and centrifuged at 12,800 g for 10 minutes
at 15°C. The pellet was washed three times in 0.1 mM
of the protease inhibitor PMSF, 0.01% Triton X100. The
final pellet was resuspended in 2–5 mL of the following
buffer: 0.1% Triton X100, Tris-HCl 0.05 M (pH 8.0),
0.01 M NaCl, and sonicated three times for one minute.
The spore-crystal mixture was layered on top of a 28 mL
discontinuous sucrose gradient, comprising 7 mL each
of 67%, 72%, 79% and 84% (w/v) sucrose in 0.01%
Triton X100, Tris-HCl 0.05 M (pH 8.0), 0.01 M NaCl.
Centrifugation was carried out in an ultracentrifuge, in
an AH627 rotor at 47,800 g for 30 min at 15°C. The
bands were collected from the interfaces, washed once
in the same volume of 0.01% Triton X100 by
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centrifugation at 12,800 g for 10 minutes, at 15°C, and twice
in 1 mL of this solution. The final pellet was resuspended
in 500 Lµ  of 0.1 Mµ  PMSF, the crystals observed by
phase-contrast microscopy and stored at -20°C.
The crystalline inclusions of strains were lyophilized
and deposited under a metallic support. The samples
were covered with gold for 180 seconds, using sputter
EMITECH model K550 and observed in a scanning
microscope.
Results and Discussion
Six B. thuringiensis strains were identified as mos-
quito toxic in the selective bioassays. Four of them
showed toxicity against A. aegypti and two against both
A. aegypti and C. quinquefasciatus (Table 1).
Even though strains were pathogenic, none of them
showed lower LC50 than B. thuringiensis israelensis
against A. aegypti. These Brazilian pathogenic strains
to A. aegypti presented similar LC50, with S479 being
the most effective among them (Table 1). Between the
pathogenic strains to C. quinquefasciatus, S550 was
as toxic as B. thuringiensis israelensis, while S447
showed a lower efficiency (Table 1).
All strains presented different protein profiles (Figure 1).
However, in all cases there is a major protein around
130 kDa, a size similar to that of the Cry4 proteins,
encoded by B. thuringiensis israelensis. On the other
hand, none of the Brazilian strains produced the expected
PCR products for cry4 genes whereas the control strain
Bti IPS82 produced the 797 bp amplicon. Strains S447,
S479, S685 and S1255 also produced a protein around
70 kDa, a similar size to the Cry11 protein (Figure 1),
but again none of the Brazilian strains yielded the 305 bp
PCR amplicon that was produced by Bti using the cry11
specific primers. The same happened when Cyt proteins
were analyzed, the strains S447 and S479 exhibited a
30 kDa protein (Figure 1) but the expected PCR product
for cyt gene (525 bp) was not amplified. These results
indicated that the activity of mosquitocidal Brazilian
strains is not related with Cry4, Cry11 or Cyt proteins.
Morphological analysis by scanning microscopy
showed that all strains produce round crystals. Strains
S447, S479, S550 and 1255 exhibited round crystals with
a size similar to Bti crystals (Figure 2). All strains except
S1255 showed also a round crystal smaller and different
from Bti crystals. It is likely that mosquitocidal activity
of these strains is linked to the presence of round crystals.
Further studies are needed to characterize the proteins
detected in this work, however, as the toxins produced
by all strains appear to be distinct from the toxins of Bti,
these strains could be used as an alternative in programs
of mosquito control.
Table 1. LC50 )mL/g(µ  of the most toxic Bacillus
thuringiensis strains identified after selective bioassays
against Aedes aegypti and Culex quinquefasciatus.
Figure 1. SDS-PAGE of spore-crystal from Bacillus
thuringiensis strains. 1: Molecular marker Gibco BRL; 2: Bti;
3: S285; 4: S447; 5: S479; 6: S550; 7: S685; 8: S1255.
Strains
Aedes aegypti
Culex quinquefasciatus
S479
S1255
S550
S447
S285
S685
IPS82-(Bti)
2.73–29.6
4.24–11.5
4.31–96.1
4.08–84.2
6.61–181
9.72–503
0.82–1.43
LC50
6.8
9.8
 15
 20
 24
 42
 1.1
Fiducial limits
S550
S447
IPS82-(Bti)
0.073
0.089
0.034
0.048–0.11
0.069–0.12
0.020–0.065
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Conclusion
Among 210 Bacillus thuringiensis strains of the
Collection of Entomopathogenic Bacillus spp. of Embrapa
Recursos Genéticos e Biotecnologia, six are toxic to Aedes
aegypti and Culex quinquefasciatus larvae.
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